Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma - correlation with clinicopathological data and comparison of antibodies
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) Book/Monograph |
| Language: | English |
| Published: |
London Berlin, Heidelberg
BioMed Central ; Springer
25 Feb. 2019
Heidelberg Universitätsbibliothek Heidelberg 25 Feb. 2019 |
| DOI: | https://doi.org/10.1186/s12885-018-5254-0 |
| Online Access: | Resolving-System, kostenfrei, Volltext: http://dx.doi.org/https://doi.org/10.1186/s12885-018-5254-0 Resolving-System, kostenfrei, Volltext: http://nbn-resolving.de/urn:nbn:de:bsz:16-heidok-259183 |
| Author Notes: | Mark Kriegsmann, Stephanie Roessler, Katharina Kriegsmann, Marcus Renner, Rémi Longuespée, Thomas Albrecht, Moritz Loeffler, Stephan Singer, Arianeb Mehrabi, Monika Nadja Vogel, Anita Pathil, Bruno Köhler, Christoph Springfeld, Christian Rupp, Karl Heinz Weiss and Benjamin Goeppert |
| Item Description: | Aus: BMC Cancer, 19 (2019), Nr. 72. pp. 1-10. ISSN 1471-2407 |
|---|---|
| Physical Description: | Online Resource |
| DOI: | https://doi.org/10.1186/s12885-018-5254-0 |